On 11/8/24, Lipocine Inc (NASDAQ: LPCN) stock suffered a major decline of -14.8%, closing at $4.76. Moreover, this decline was accompanied by unusually high trading volume at 198% of normal. The stock has performed in line with the market over the last nine months and has declined -14.1% during the last week.
Current PriceTarget Research Rating
LPCN’s future returns on capital are forecasted to fall short of the cost of capital. Accordingly, the company is expected to continue to be a modest Value Eraser.
Lipocine has a current Value Trend Rating of C (Neutral). This rating combines highly consistent signals from two proprietary PTR measures of a stock’s attractiveness. Lipocine has a neutral Appreciation Score of 58 and a neutral Power Rating of 49, resulting in the Neutral Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment